Related Experiment Video

Updated: Aug 20, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Baerveldt glaucoma implant in the management of refractory childhood glaucomas

Donald L Budenz1, Steven J Gedde, James D Brandt

  • 1Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, Florida 33136, USA. dbudenz@med.miami.edu

Ophthalmology
|December 8, 2004
PubMed

Insights

The Baerveldt glaucoma drainage implant (GDI) effectively lowers intraocular pressure in children with refractory glaucomas. While generally safe, potential risks like retinal detachment warrant consideration in pediatric glaucoma management.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Glaucoma Management

Background:

  • Pediatric glaucomas are complex conditions requiring effective long-term management.
  • Glaucoma drainage implants (GDIs) are utilized when medical or other surgical treatments fail.

Purpose of the Study:

  • To assess the efficacy and safety of the Baerveldt GDI in treating pediatric glaucomas.
  • To compare outcomes between primary and secondary pediatric glaucoma cases.

Main Methods:

  • Retrospective case series of 62 children (<18 years) who received Baerveldt GDI surgery.
  • Evaluated intraocular pressure (IOP), complications, medication use, and visual acuity.
  • Success defined by IOP control, absence of vision loss, and no further glaucoma surgery.

Main Results:

  • Mean IOP decreased from 35.0 mmHg preoperatively to 17.6 mmHg postoperatively (P<0.001).
  • Cumulative success rates were 85% at 6 months and 60% by 24 months.
  • No significant differences in outcomes were observed between primary and secondary glaucoma groups.

Conclusions:

  • Baerveldt GDI surgery demonstrates effectiveness for refractory glaucomas in children.
  • Retinal detachment is a potential complication associated with the implant or other ocular factors.
Abstract

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...